Bio Other Assets vs Deferred Long Term Liab Analysis

BIO Stock

USD 275.94 0.34 0.12%

Bio Rad financial indicator trend analysis is way more than just evaluating Bio Rad Laboratories prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Bio Rad Laboratories is a good investment. Please check the relationship between Bio Rad Other Assets and its Deferred Long Term Liab accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bio Rad Laboratories. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product.

Other Assets vs Deferred Long Term Liab

Other Assets vs Deferred Long Term Liab Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Bio Rad Laboratories Other Assets account and Deferred Long Term Liab. At this time, the significance of the direction appears to have significant contrarian relationship.

The correlation between Bio Rad's Other Assets and Deferred Long Term Liab is -0.41. Overlapping area represents the amount of variation of Other Assets that can explain the historical movement of Deferred Long Term Liab in the same time period over historical financial statements of Bio Rad Laboratories, assuming nothing else is changed. The correlation between historical values of Bio Rad's Other Assets and Deferred Long Term Liab is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Other Assets of Bio Rad Laboratories are associated (or correlated) with its Deferred Long Term Liab. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Deferred Long Term Liab has no effect on the direction of Other Assets i.e., Bio Rad's Other Assets and Deferred Long Term Liab go up and down completely randomly.

Correlation Coefficient

-0.41

Relationship Direction	Negative
Relationship Strength	Very Weak

View All Relationships

Other Assets

Deferred Long Term Liab

Liabilities that are due after more than one year, including deferred tax liabilities and deferred revenue.

Most indicators from Bio Rad's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Bio Rad Laboratories current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bio Rad Laboratories. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product.

At this time, Bio Rad's Sales General And Administrative To Revenue is very stable compared to the past year. As of the 28th of April 2024, Enterprise Value is likely to grow to about 1 B, while Selling General Administrative is likely to drop about 481.6 M.

	2021	2022	2023	2024 (projected)
Gross Profit	1.6B	1.6B	1.4B	769.3M
Total Revenue	2.9B	2.8B	2.7B	1.4B

Gross Profit Total Revenue

Bio Rad fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Short Term Debt	Accounts Payable	Intangible Assets	Common Stock Total Equity	Common Stock
Total Assets		0.27	-0.41	0.51	1.0	0.85	0.14	1.0	0.3	0.99	-0.97	0.71	0.4	0.46	0.97	0.71	-0.02	-0.19	0.98	0.93	0.69	0.08	0.58	0.42	-0.37	-0.37
Short Long Term Debt Total	0.27		-0.75	-0.03	0.22	0.43	0.95	0.27	-0.08	0.18	-0.05	0.81	0.28	0.22	0.47	0.63	0.23	-0.7	0.45	0.52	0.76	0.0	-0.28	0.51	-0.33	-0.33
Other Current Liab	-0.41	-0.75		0.13	-0.38	-0.45	-0.75	-0.44	0.24	-0.36	0.27	-0.61	-0.02	-0.04	-0.54	-0.56	0.08	0.86	-0.5	-0.67	-0.58	-0.01	0.3	-0.22	0.1	0.1
Total Current Liabilities	0.51	-0.03	0.13		0.5	0.72	-0.29	0.46	0.85	0.48	-0.49	0.43	0.72	0.78	0.4	0.53	0.37	0.48	0.5	0.34	0.5	0.59	0.69	0.39	-0.7	-0.7
Total Stockholder Equity	1.0	0.22	-0.38	0.5		0.83	0.08	1.0	0.3	1.0	-0.98	0.67	0.38	0.44	0.96	0.68	-0.04	-0.16	0.97	0.92	0.65	0.08	0.59	0.39	-0.35	-0.35
Property Plant And Equipment Net	0.85	0.43	-0.45	0.72	0.83		0.2	0.82	0.55	0.8	-0.74	0.84	0.65	0.78	0.83	0.92	0.26	-0.06	0.88	0.85	0.89	0.29	0.6	0.48	-0.72	-0.72
Net Debt	0.14	0.95	-0.75	-0.29	0.08	0.2		0.15	-0.38	0.06	0.06	0.64	0.07	-0.04	0.35	0.44	0.12	-0.81	0.3	0.41	0.57	-0.13	-0.45	0.38	-0.07	-0.07
Retained Earnings	1.0	0.27	-0.44	0.46	1.0	0.82	0.15		0.25	0.99	-0.97	0.69	0.34	0.4	0.97	0.67	-0.06	-0.23	0.97	0.93	0.67	0.09	0.53	0.39	-0.31	-0.31
Cash	0.3	-0.08	0.24	0.85	0.3	0.55	-0.38	0.25		0.27	-0.28	0.32	0.7	0.76	0.21	0.42	0.37	0.54	0.31	0.18	0.39	0.37	0.6	0.37	-0.73	-0.73
Non Current Assets Total	0.99	0.18	-0.36	0.48	1.0	0.8	0.06	0.99	0.27		-0.99	0.63	0.34	0.39	0.95	0.63	-0.08	-0.16	0.95	0.9	0.61	0.07	0.58	0.36	-0.3	-0.3
Non Currrent Assets Other	-0.97	-0.05	0.27	-0.49	-0.98	-0.74	0.06	-0.97	-0.28	-0.99		-0.53	-0.3	-0.36	-0.9	-0.54	0.12	0.08	-0.91	-0.85	-0.51	-0.08	-0.62	-0.31	0.24	0.24
Cash And Short Term Investments	0.71	0.81	-0.61	0.43	0.67	0.84	0.64	0.69	0.32	0.63	-0.53		0.55	0.57	0.81	0.89	0.22	-0.39	0.82	0.83	0.97	0.16	0.28	0.59	-0.58	-0.58
Net Receivables	0.4	0.28	-0.02	0.72	0.38	0.65	0.07	0.34	0.7	0.34	-0.3	0.55		0.88	0.4	0.71	0.74	0.3	0.46	0.37	0.68	0.02	0.56	0.76	-0.88	-0.88
Common Stock Shares Outstanding	0.46	0.22	-0.04	0.78	0.44	0.78	-0.04	0.4	0.76	0.39	-0.36	0.57	0.88		0.42	0.8	0.64	0.39	0.5	0.41	0.72	0.13	0.67	0.54	-0.97	-0.97
Non Current Liabilities Total	0.97	0.47	-0.54	0.4	0.96	0.83	0.35	0.97	0.21	0.95	-0.9	0.81	0.4	0.42		0.76	0.01	-0.35	0.99	0.97	0.78	0.0	0.44	0.51	-0.37	-0.37
Inventory	0.71	0.63	-0.56	0.53	0.68	0.92	0.44	0.67	0.42	0.63	-0.54	0.89	0.71	0.8	0.76		0.43	-0.18	0.79	0.8	0.97	0.07	0.45	0.57	-0.78	-0.78
Other Current Assets	-0.02	0.23	0.08	0.37	-0.04	0.26	0.12	-0.06	0.37	-0.08	0.12	0.22	0.74	0.64	0.01	0.43		0.26	0.06	-0.02	0.39	-0.12	0.11	0.59	-0.7	-0.7
Other Stockholder Equity	-0.19	-0.7	0.86	0.48	-0.16	-0.06	-0.81	-0.23	0.54	-0.16	0.08	-0.39	0.3	0.39	-0.35	-0.18	0.26		-0.28	-0.45	-0.28	0.15	0.62	-0.14	-0.29	-0.29
Total Liab	0.98	0.45	-0.5	0.5	0.97	0.88	0.3	0.97	0.31	0.95	-0.91	0.82	0.46	0.5	0.99	0.79	0.06	-0.28		0.96	0.81	0.09	0.5	0.52	-0.45	-0.45
Property Plant And Equipment Gross	0.93	0.52	-0.67	0.34	0.92	0.85	0.41	0.93	0.18	0.9	-0.85	0.83	0.37	0.41	0.97	0.8	-0.02	-0.45	0.96		0.81	0.01	0.36	0.47	-0.37	-0.37
Total Current Assets	0.69	0.76	-0.58	0.5	0.65	0.89	0.57	0.67	0.39	0.61	-0.51	0.97	0.68	0.72	0.78	0.97	0.39	-0.28	0.81	0.81		0.1	0.35	0.64	-0.73	-0.73
Short Term Debt	0.08	0.0	-0.01	0.59	0.08	0.29	-0.13	0.09	0.37	0.07	-0.08	0.16	0.02	0.13	0.0	0.07	-0.12	0.15	0.09	0.01	0.1		0.11	-0.22	-0.07	-0.07
Accounts Payable	0.58	-0.28	0.3	0.69	0.59	0.6	-0.45	0.53	0.6	0.58	-0.62	0.28	0.56	0.67	0.44	0.45	0.11	0.62	0.5	0.36	0.35	0.11		0.15	-0.51	-0.51
Intangible Assets	0.42	0.51	-0.22	0.39	0.39	0.48	0.38	0.39	0.37	0.36	-0.31	0.59	0.76	0.54	0.51	0.57	0.59	-0.14	0.52	0.47	0.64	-0.22	0.15		-0.64	-0.64
Common Stock Total Equity	-0.37	-0.33	0.1	-0.7	-0.35	-0.72	-0.07	-0.31	-0.73	-0.3	0.24	-0.58	-0.88	-0.97	-0.37	-0.78	-0.7	-0.29	-0.45	-0.37	-0.73	-0.07	-0.51	-0.64		1.0
Common Stock	-0.37	-0.33	0.1	-0.7	-0.35	-0.72	-0.07	-0.31	-0.73	-0.3	0.24	-0.58	-0.88	-0.97	-0.37	-0.78	-0.7	-0.29	-0.45	-0.37	-0.73	-0.07	-0.51	-0.64	1.0

Click cells to compare fundamentals

Bio Rad Account Relationship Matchups

Bio Rad fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	8.0B	13.0B	17.8B	13.5B	12.3B	12.9B
Short Long Term Debt Total	439.8M	14.1M	11.0M	1.2B	1.4B	1.5B
Other Current Liab	158.5M	224.9M	210.7M	186.2M	(35.4B)	(33.6B)
Total Current Liabilities	905.5M	631.5M	680.9M	568.7M	522.8M	338.4M
Total Stockholder Equity	5.8B	9.9B	13.7B	9.6B	8.7B	9.2B
Property Plant And Equipment Net	701.2M	693.5M	695.8M	679.6M	723.7M	759.9M
Net Debt	(220.9M)	(648.1M)	(459.8M)	764.0M	1.0B	1.1B
Retained Earnings	5.5B	9.3B	13.5B	9.9B	9.3B	9.7B
Cash	660.7M	662.2M	470.8M	434.2M	404.0M	257.1M
Non Current Assets Total	5.8B	10.8B	15.8B	10.3B	9.3B	9.7B
Non Currrent Assets Other	(997.7B)	(2.1T)	(3.1T)	(1.8T)	(1.5T)	(1.4T)
Cash And Short Term Investments	1.1B	996.7M	875.5M	1.8B	1.6B	1.7B
Net Receivables	392.7M	419.4M	423.5M	494.6M	500.9M	272.8M
Common Stock Shares Outstanding	30.2M	30.2M	30.2M	29.8M	29.2M	29.1M
Liabilities And Stockholders Equity	8.0B	13.0B	17.8B	13.5B	12.3B	12.9B
Non Current Liabilities Total	1.3B	2.5B	3.4B	3.3B	3.0B	3.2B
Inventory	554.0M	622.3M	572.2M	719.3M	780.5M	819.5M
Other Current Assets	113.3M	101.5M	117.8M	147.8M	154.0M	91.6M
Other Stockholder Equity	371.6M	329.5M	335.4M	183.9M	(183.5M)	(174.3M)
Total Liab	2.3B	3.1B	4.1B	3.9B	3.6B	3.7B
Property Plant And Equipment Gross	701.2M	1.5B	1.5B	1.5B	1.8B	1.9B
Total Current Assets	2.2B	2.1B	2.0B	3.2B	3.0B	3.2B
Accumulated Other Comprehensive Income	(87.3M)	282.5M	(175.6M)	(466.8M)	(336.0M)	(319.2M)
Short Term Debt	426.2M	1.8M	489K	465K	41.4M	30.8M
Accounts Payable	287.1M	362.3M	418.9M	329.8M	142.8M	138.4M
Intangible Assets	145.5M	199.5M	253.9M	332.1M	320.5M	188.7M
Other Assets	40.3M	13K	82K	94.6M	85.1M	73.6M
Long Term Debt	13.6M	12.3M	10.5M	1.2B	1.2B	1.3B
Good Will	264.1M	291.9M	347.3M	406.5M	413.6M	339.1M
Treasury Stock	(38.4M)	(99.9M)	(106.3M)	(263.6M)	(237.2M)	(225.4M)
Property Plant Equipment	499.3M	491.4M	695.8M	498.6M	573.4M	371.9M
Current Deferred Revenue	33.7M	42.5M	50.9M	52.2M	35.8B	37.5B
Other Liab	1.2B	2.4B	3.4B	2.0B	2.3B	2.4B
Short Term Investments	459.5M	334.5M	404.7M	1.4B	1.2B	1.3B
Net Tangible Assets	5.8B	9.9B	13.1B	9.2B	10.6B	11.1B
Retained Earnings Total Equity	5.5B	9.3B	13.5B	9.9B	11.4B	12.0B
Capital Surpluse	410.0M	429.4M	441.7M	447.5M	514.6M	366.5M
Deferred Long Term Liab	997.8M	2.1B	3.1B	1.8B	2.0B	2.1B

Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Bio Rad in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Bio Rad's short interest history, or implied volatility extrapolated from Bio Rad options trading.

Pair Trading with Bio Rad

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Bio Rad position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bio Rad will appreciate offsetting losses from the drop in the long position's value.

Moving against Bio Stock

0.77	ELYM	Eliem Therapeutics Upward Rally	Pair Corr
0.66	ACB	Aurora Cannabis Sell-off Trend	Pair Corr
0.42	CGC	Canopy Growth Corp Financial Report 27th of June 2024	Pair Corr

The ability to find closely correlated positions to Bio Rad could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Bio Rad when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Bio Rad - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Bio Rad Laboratories to buy it.

The correlation of Bio Rad is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Bio Rad moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Bio Rad Laboratories moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for Bio Rad can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

When determining whether Bio Rad Laboratories offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Bio Rad's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Bio Rad Laboratories Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Bio Rad Laboratories Stock:

How To Invest In Bio

Details

Is Bio Stock a good investment?

Details

What is Bio Rad's Net Worth?

Details

Largest Life Sciences Tools & Services Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bio Rad Laboratories. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product.

You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.

Complementary Tools for Bio Stock analysis

When running Bio Rad's price analysis, check to measure Bio Rad's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bio Rad is operating at the current time. Most of Bio Rad's value examination focuses on studying past and present price action to predict the probability of Bio Rad's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bio Rad's price. Additionally, you may evaluate how the addition of Bio Rad to your portfolios can decrease your overall portfolio volatility.

	Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios
	Portfolio Anywhere Track or share privately all of your investments from the convenience of any device
	Risk-Return Analysis View associations between returns expected from investment and the risk you assume
	Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules
	AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities
	Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market.
	Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
	ETFs Find actively traded Exchange Traded Funds (ETF) from around the world

Is Bio Rad's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bio Rad. If investors know Bio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bio Rad listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

(0.56)

Earnings Share

(21.83)

Revenue Per Share

91.453

Quarterly Revenue Growth

(0.07)

Return On Assets

0.0177

The market value of Bio Rad Laboratories is measured differently than its book value, which is the value of Bio that is recorded on the company's balance sheet. Investors also form their own opinion of Bio Rad's value that differs from its market value or its book value, called intrinsic value, which is Bio Rad's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bio Rad's market value can be influenced by many factors that don't directly affect Bio Rad's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Bio Rad's value and its price as these two are different measures arrived at by different means. Investors typically determine if Bio Rad is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bio Rad's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Bio Other Assets vs Deferred Long Term Liab Analysis

Other Assets vs Deferred Long Term Liab

Other Assets vs Deferred Long Term Liab Correlation Analysis

Correlation Coefficient

Other Assets

Deferred Long Term Liab

Bio Rad fundamental ratios Correlations

Bio Rad Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Bio Rad fundamental ratios Accounts

Pair Trading with Bio Rad

Moving against Bio Stock

Complementary Tools for Bio Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Stockholder Equity	+ 1.0	Total Assets
Retained Earnings	+ 1.0	Total Assets
Retained Earnings	+ 1.0	Total Stockholder Equity
Non Current Assets Total	+ 1.0	Total Stockholder Equity
Common Stock	+ 1.0	Common Stock Total Equity
Non Current Assets Total	+ 0.99	Total Assets

Non Currrent Assets Other	- 0.99	Non Current Assets Total
Non Currrent Assets Other	- 0.98	Total Stockholder Equity
Common Stock	- 0.97	Common Stock Shares Outstanding
Common Stock Total Equity	- 0.97	Common Stock Shares Outstanding
Non Currrent Assets Other	- 0.97	Retained Earnings
Non Currrent Assets Other	- 0.97	Total Assets